<DOC>
	<DOCNO>NCT02657707</DOCNO>
	<brief_summary>A prospective , multicenter , single-arm , open label clinical study evaluate safety effectiveness MicroVention , Inc. Roadsaver™ Carotid Stent System use conjunction Nanoparasol® embolic protection system treatment carotid artery stenosis patient elevate risk adverse event follow carotid endarterectomy .</brief_summary>
	<brief_title>Evaluation Roadsaver Stent Used Conjunction With Nanoparasol Embolic Protection System Carotid Artery Stenosis</brief_title>
	<detailed_description>A total 295 patient enrol study . All potential patient consider study diagnose significant carotid artery stenosis consider high perioperative risk carotid endarterectomy . Patients evaluate screen , pre-procedure , index procedure , post-procedure . Follow-up visit complete 30 day , 6 month , 12 , 24 , 36 month post-procedure .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Carotid Stenosis</mesh_term>
	<criteria>1 . Patient &gt; 21 ≤80 year age . 2 . Patient willing capable comply study protocol requirement , include specify followup period contact telephone . 3 . Patient authorized legal representative willing provide write informed consent prior enrollment study . 4 . Patient diagnose carotid artery stenosis consider high operative risk carotid endarterectomy . 5 . Patient either : Symptomatic carotid stenosis ≥50 % determine angiography use NASCET methodology . Symptomatic define amaurosis fugax ipsilateral carotid lesion ; TIA nondisabling stroke within 180 day procedure within hemisphere supply target vessel ; Asymptomatic carotid stenosis ≥80 % determine angiography use NASCET methodology . 6 . Patient target lesion locate carotid bifurcation and/or proximal ICA . 7 . Patient single de novo restenotic ( post CEA ) target lesion severe tandem lesion close enough covered single Roadsaver™ stent . 8 . Patients vessel reference diameter 3.0 mm 9.0 mm target lesion . High Risk Inclusion Criteria For inclusion study , patient must qualify least one anatomic comorbid highrisk condition , show : Anatomic High Risk Conditions : 1 . Patient target lesion second vertebral body ( level jaw ) clavicle . 2 . Patient inability extend head due cervical arthritis cervical disorder . 3 . Patient status/post radiation therapy neck . 4 . Patient prior head neck surgery region carotid artery . 5 . Patient spinal immobility neck . 6 . Patient presence tracheostomy stoma . 7 . Patient laryngeal palsy laryngectomy . 8 . Patient hostile neck surgically inaccessible lesion . 9 . Patient severe tandem lesion . Comorbid High Risk Conditions : 1 . Patient ≥70 year age ( maximum 80 year ) time enrollment . 2 . Patient NYHA Class III IV congestive heart failure ( CHF ) FEV &lt; 35 % . 3 . Patient chronic obstructive pulmonary disease ( COPD ) . 4 . Patient leave ventricular ejection fraction ( LVEF ) &lt; 35 % . 5 . Patient unstable angina . 6 . Patient recent myocardial infarction ( ≥30 day prior stenting procedure ) . 7 . Patient coronary artery disease two vessel ≥ 70 % stenosis . 8 . Patient plan CABG valve replacement surgery 31‐60 day CAS procedure . 9 . Patient require peripheral vascular surgery abdominal aortic aneurysm repair 31‐60 day follow CAS procedure . 10 . Patient contralateral laryngeal nerve paralysis 11 . Patient restenosis previous CEA . 1 . Patient life expectancy le one year . 2 . Patient experience ( experience ) evolving , acute , recent disable stroke last 30 day . 3 . Patient anticipate potential source emboli ( e.g . know previously symptomatic patent foramen ovale ( PFO ) , mechanical heart valve , deep vein thrombosis ( DVT ) treat within 6 month ) adequately treated anticoagulant least two week document coagulation parameter target therapeutic range . 4 . Patient atrial fibrillation . 5 . Patient acute myocardial infarction within 60 day prior index procedure . 6 . Patient plan major surgical procedure ( i.e . intraabdominal intrathoracic surgery surgery/interventional procedure involve cardiac vascular system ) within 30 day index procedure . 7 . Patient history major ipsilateral stroke . 8 . Patient know severe carotid stenosis complete occlusion contralateral target lesion require treatment within 30 day follow index procedure . 9 . Patient modify Rankin Scale &gt; 2 another neurological deficit due stroke may confound neurological patient assessment . 10 . Patient chronic renal insufficiency ( serum creatinine ≥2.5 mg/dL ) history severe hepatic impairment , malignant hypertension , and/or morbidly obese . 11 . Patient platelet count &lt; 100,000/μL . 12 . Patient known sensitivity heparin previous incidence Heparin‐Induced Thrombocytopenia ( HIT ) type II . 13 . Patient contraindication standard care study medication , include antiplatelet therapy . 14 . Patient known sensitivity contrast medium adequately control premedication . 15 . Patient known bleed diathesis hypercoagulable state refuse blood transfusion . 16 . Patient intracranial pathology , opinion investigator , make patient inappropriate study participation ( e.g . brain tumor , AVM , cerebral aneurysm , cerebral vascular disease [ microangiopathy large vessel ] , etc . ) would confound neurological evaluation . 17 . Patient intracranial hemorrhage within last 90 day . 18 . Patient currently enrol another investigational study protocol complete primary endpoint confound current study endpoint . Patients involved long‐term surveillance clinical study eligible . 19 . Patient suffers confusion dementia unable unwilling cooperate study requirement and/or follow‐up procedure . 20 . Patient know , unresolved history drug use alcohol dependency . 21 . Patient active infection . 22 . Patient renal failure and/or dialysis . 23 . Patient document uncontrolled diabetes . 24 . Patient pregnant . Angiographic Exclusion Criteria A patient eligible enrollment study he/she meet follow angiographic exclusion criterion : 1 . Patient total occlusion target carotid artery ( i.e. , CCA ICA ) . 2 . Patient previously place stent ipsilateral carotid artery . 3 . Patient severe lesion calcification vascular tortuosity may preclude safe introduction sheath , guide catheter , embolic protection system , stent . 4 . Patient presence mobile fill defect thrombus target vessel . 5 . Patient occlusion presence `` string sign '' target vessel . 6 . Patient carotid ( intracranial ) stenosis locate distal target stenosis severe target stenosis . 7 . Patient know mobile plaque thrombus aortic arch . 8 . Patient type III aortic arch . 9 . Patient femoral access possible . 10 . Patient arteriovenous malformation territory target carotid artery .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>stent</keyword>
	<keyword>stenosis</keyword>
	<keyword>artery</keyword>
	<keyword>carotid</keyword>
</DOC>